GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO., LTD.

Autres langues Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Actions

874 CNE100000387

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:05 02/07/2024			Varia. 5j.	Varia. 1 janv.
20,75 ^HKD	+0,48%		+0,48%	-4,60%

27/06	Guangzhou Baiyunshan Pharmaceutical obtient l'enregistrement de ses comprimés contre les troubles de l'érection	MT
19/06	L'unité de Baiyunshan Pharmaceutical reçoit le feu vert réglementaire pour ajouter une spécification à l'injection de chlorhydrate de dopamine	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Guangzhou Baiyunshan Pharmaceutical Secures Drug Registration for Erectile Dysfunction Tablets	27/06
Baiyunshan Pharmaceutical's Unit Gets Regulatory Nod to Add Specification for Dopamine Hydrochloride Injection	19/06
Baiyunshan Pharmaceutical's Unit Gets Nod from Macao's Drug Regulator to Import, Export Pearl Powder	17/06
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Baiyunshan Pharmaceutical's 2023 Profit Rises 2%	18/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024	15/03
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Baiyunshan Pharma's Unit Gets Green Light to Produce Hepatitis B Drug	01/03
Guangzhou Pharma Unit Gets Green Light to Trial Oral Liquid Drug	09/02
Guangzhou Baiyunshan Pharmaceutical Arm Floats 1 Billion Yuan Biomedical VC Fund	19/12
Guangzhou Baiyunshan Pharmaceutical Ends Spin-Off Plans, Seeks China Listing for Subsidiary	19/12
Guangzhou Pharma Expands Scope of Drug Production License	13/11
Guangzhou Baiyunshan Pharmaceutical's Profit Up 11% in Q3	30/10/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Baiyunshan Pharmaceutical Reports Increase in H1 Attributable Profit	13/09/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to Shanghai Stock Exchange 180 Value Index	12/06/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(SHSE:600332) added to SSE 180 Index	12/06/23
Guangzhou Pharma Registers Pain-Relief, Anti-Inflammatory Drugs in Russia	26/05/23
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2023	27/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd.

Actions

874

CNE100000387

Autres langues

Filtres